Transcription of STABILITY TESTING OF ACTIVE PHARMACEUTICAL …
{{id}} {{{paragraph}}}
Example: air traffic controller
STABILITY TESTING OF ACTIVE PHARMACEUTICAL …
Working document January 2017. Draft document for comment 1 STABILITY TESTING OF ACTIVE . 2 PHARMACEUTICAL ingredients AND. 3 finished PHARMACEUTICAL PRODUCTS. 4 (January 2017). 5 DRAFT FOR COMMENT. Should you have any comments on the attached text and the STABILITY conditions for WHO Member States (MS) by Region, appendixed to the previous version of this guidance ( ), please send these to: Dr Sabine Kopp, Group Lead, Medicines Quality Assurance, Technologies Standards and Norms, World Health Organization, 1211 Geneva 27, Switzerland; email: fax: (+41 22) 791 4730;. and to Mrs Ksenia Finnerty by 15 March 2017.
Working document QAS/17.694 January 2017 Draft document for comment 1 STABILITY TESTING OF ACTIVE 2 PHARMACEUTICAL INGREDIENTS AND 3 FINISHED PHARMACEUTICAL PRODUCTS ...
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Q 1 A, Stability Testing of new Drug, STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS, Guideline, ICH Q1A guideline, ICH Q1A(R2) Guideline Stability Testing of New, International conference on harmonisation, Guideline stability testing of new, STABILITY TESTING OF NEW, Long Term Stability Testing Conditions:, Long Term Stability Testing Conditions: Position, Stability Workshop ICH Q1F C, Guideline Stability, Shelf-Life Determination, ICH guideline, Stability, Q10 Questions and Answers, Q10 - questions and answers, IMPURITIES IN EW DRUG SUBSTANCES